Condition: Cystic Fibrosis · Sponsor: Charite University, Berlin, Germany
This observational study evaluates the effect of therapy with cystic fibrosis transmembrane regulator (CFTR) modulators on CFTR function measured by the CFTR biomarker intestinal current measurement (ICM), nasal potential difference (NPD) and sweat chloride in a post-approval setting in patients with cystic fibrosis (CF).
This description comes directly from the study's public registry record.
Simon Y Graeber, MD · +4930 450 566 587 · simon.graeber@charite.de
Always discuss trial participation with your own doctor first.
| Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Recruiting |
| Justus-Liebig-University Giessen | Giessen, Germany | Recruiting |
| Hannover Medical School | Hanover, Germany | Recruiting |
| University of Heidelberg | Heidelberg, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04732910